Steven Xu

Steven Xu

Johnson & Johnson Co. - New Jersey / United States
Engineering & Technology / Computer Science
AD Scientific Index ID: 4382875
-
person_outline Steven Xu's MOST POPULAR ARTICLES
1-) Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 …MV Mateos, H Nahi, W Legiec, S Grosicki, V Vorobyev, I Spicka, ...The lancet haematology 7 (5), e370-e380, 20201672020
2-) Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myelomaT Casneuf, XS Xu, HC Adams III, AE Axel, C Chiu, I Khan, T Ahmadi, ...Blood advances 1 (23), 2105-2114, 20171702017
3-) Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketonesX Xu, TM Mariano, JD Laskin, CP WeiselToxicology and Applied Pharmacology 184 (1), 19-26, 20021692002
4-) Selective detection of monohydroxy metabolites of polycyclic aromatic hydrocarbons in urine using liquid chromatography/triple quadrupole tandem mass spectrometryX Xu, J Zhang, L Zhang, W Liu, CP WeiselRapid Communications in Mass Spectrometry 18 (19), 2299-2308, 20041322004
5-) Simultaneous and sensitive measurement of anabasine, nicotine, and nicotine metabolites in human urine by liquid chromatography–tandem mass spectrometryX Xu, MM Iba, CP WeiselClinical Chemistry 50 (12), 2323-2330, 20041282004